| Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia F Lo-Coco, G Cimino, M Breccia, NI Noguera, D Diverio, E Finolezzi, ... Blood 104 (7), 1995-1999, 2004 | 304 | 2004 |
| GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children AM Testi, A Biondi, FL Coco, ML Moleti, F Giona, M Vignetti, G Menna, ... Blood 106 (2), 447-453, 2005 | 266 | 2005 |
| Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia A Pession, R Masetti, C Rizzari, MC Putti, F Casale, F Fagioli, M Luciani, ... Blood, The Journal of the American Society of Hematology 122 (2), 170-178, 2013 | 217 | 2013 |
| Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial F Locatelli, G Zugmaier, C Rizzari, JD Morris, B Gruhn, T Klingebiel, ... Jama 325 (9), 843-854, 2021 | 216 | 2021 |
| Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia V Conter, M Aricò, G Basso, A Biondi, E Barisone, C Messina, R Parasole, ... Leukemia 24 (2), 255-264, 2010 | 213 | 2010 |
| Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry V Cetica, E Sieni, D Pende, C Danesino, C De Fusco, F Locatelli, ... Journal of Allergy and Clinical Immunology 137 (1), 188-196. e4, 2016 | 181 | 2016 |
| Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis V Conter, MG Valsecchi, B Buldini, R Parasole, F Locatelli, A Colombini, ... The Lancet Haematology 3 (2), e80-e86, 2016 | 115 | 2016 |
| Long-term results of the AIEOP-ALL-95 trial for childhood acute lymphoblastic leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt … M Arico, MG Valsecchi, C Rizzari, E Barisone, A Biondi, F Casale, ... Journal of Clinical Oncology 26 (2), 283-289, 2008 | 109 | 2008 |
| Long-term results of the AIEOP-ALL-95 trial for childhood acute lymphoblastic leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt … M Arico, MG Valsecchi, C Rizzari, E Barisone, A Biondi, F Casale, ... Journal of Clinical Oncology 26 (2), 283-289, 2008 | 109 | 2008 |
| Novel Munc13–4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis A Santoro, S Cannella, G Bossi, F Gallo, A Trizzino, D Pende, F Dieli, ... Journal of medical genetics 43 (12), 953-960, 2006 | 97 | 2006 |
| Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study V Conter, MG Valsecchi, R Parasole, MC Putti, F Locatelli, E Barisone, ... Blood, The Journal of the American Society of Hematology 123 (10), 1470-1478, 2014 | 89 | 2014 |
| Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution E Castagnola, I Caviglia, A Pistorio, F Fioredda, C Micalizzi, C Viscoli, ... European Journal of Cancer 41 (10), 1439-1445, 2005 | 83 | 2005 |
| Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia Y Ma, SE Dobbins, AL Sherborne, D Chubb, M Galbiati, G Cazzaniga, ... Proceedings of the National Academy of Sciences 110 (18), 7429-7433, 2013 | 74 | 2013 |
| Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP‐AML 2002/01 study protocol B Buldini, F Rizzati, R Masetti, F Fagioli, G Menna, C Micalizzi, MC Putti, ... British journal of haematology 177 (1), 116-126, 2017 | 73 | 2017 |
| Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative ML Randi, MC Putti, M Scapin, E Pacquola, F Tucci, C Micalizzi, ... Blood 108 (10), 3600-3602, 2006 | 67 | 2006 |
| Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary … F Minoia, F Bovis, S Davi, A Insalaco, K Lehmberg, S Shenoi, S Weitzman, ... The Journal of pediatrics 189, 72-78. e3, 2017 | 64 | 2017 |
| Mycophenolate mofetil and sirolimus as second or further line treatment in children with chronic refractory primitive or secondary autoimmune cytopenias: a single centre experience M Miano, M Scalzone, K Perri, E Palmisani, I Caviglia, C Micalizzi, ... British journal of haematology 171 (2), 247-253, 2015 | 63 | 2015 |
| Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients M Miano, A Pistorio, MC Putti, C Dufour, C Messina, E Barisone, O Ziino, ... Leukemia & lymphoma 53 (9), 1693-1698, 2012 | 58 | 2012 |
| Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response G Cazzaniga, M Lanciotti, V Rossi, D Di Martino, M Arico, MG Valsecchi, ... British journal of haematology 119 (2), 445-453, 2002 | 56 | 2002 |
| Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations E Manara, V Bisio, R Masetti, V Beqiri, R Rondelli, G Menna, C Micalizzi, ... Leukemia 28 (5), 1132-1134, 2014 | 54 | 2014 |
